Physician profile
Daniel Morrison
NPI 1225484603
$2,933.71
in general payments reported to CMS, 2019-2025
8 companies · $2,344 in 2025
The $2,344 reported for 2025 was more than what 91% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $283 · 2024: $306 · 2025: $2,344.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,495 · Food and Beverage: $1,439.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,494.94 |
| Food and Beverage | $1,438.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Med-El Corporation | $1,744.73 | 2024-2025 | Mi1250 Synchrony 2 Flexsoft, Bci 602 Kit, Adhear Professional Kit |
| Genzyme Corporation | $518.97 | 2023-2025 | |
| Cochlear Americas | $182.60 | 2023-2025 | Osia Osi300 Implant, Baha, Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode |
| Medtronic, INC. | $153.34 | 2025 | Stealthstation S8 Platform |
| Regeneron Healthcare Solutions, INC. | $147.23 | 2023-2024 | Dupixent |
| Glaxosmithkline, LLC. | $80.23 | 2025 | Nucala |
| Advanced Bionics, LLC | $61.18 | 2025 | Hires Ultra Ci Hifocus Ms Electrode |
| Smith+Nephew, INC. | $45.43 | 2023-2025 | Stravix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Morrison listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.